Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample

被引:92
作者
Leidy, NK
Coughlin, C
机构
[1] MEDTAP Int Inc, Ctr Hlth Outcomes Res, Bethesda, MD 20814 USA
[2] United HealthCare Corp, Minnetonka, MN USA
关键词
asthma; quality of life; methodology; measurement; psychometrics;
D O I
10.1023/A:1008853325724
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The purpose of this study was to examine the psychometric characteristics of the Juniper Asthma Quality of Life Questionnaire (AQLQ) in a sample of asthmatics from the USA, employing data from the Asthma Symptom Utility Index (ASUI) validation study. One hundred and sixty-one adults (66 men) undergoing standard care in an asthma clinic participated in the study (mean age = 34.7 +/- 10.7 years, mean duration of illness = 17.3 +/- 11.22 years and mean FEV1% predicted = 85.6% +/- 17.1%). The internal consistency reliability (proportional to) ranged from 0.90 (environment subscale) to 0.95 (overall score) and the 2 week reproducibility (ICC) ranged from 0.81 (activities subscale) to 0.93 (symptoms subscale). The AQLQ was significantly correlated with an asthma disease severity scale and the Health Utilities Index (p < 0.001). No relationship was found between the AQLQ score and FEV1% predicted. Men reported better overall quality of life (QoL), fewer activity limitations and less environmental exposure than women (p < 0.01), while patients with a high school education or less had more severe asthma and poorer QoL across all subscales (p < 0.001). This may reflect the differential experiences of asthma across gender and socioeconomic groups. The results suggest that the AQLQ may be a useful outcome measure for clinical trials conducted in the USA.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 40 条
[1]   Impact of the global on patient perceivable change in an asthma specific QOL questionnaire [J].
Barber, BL ;
Santanello, NC ;
Epstein, RS .
QUALITY OF LIFE RESEARCH, 1996, 5 (01) :117-122
[2]   THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].
BERGNER, M ;
BOBBITT, RA ;
CARTER, WB ;
GILSON, BS .
MEDICAL CARE, 1981, 19 (08) :787-805
[3]  
Cella DF, 1996, QUALITY LIFE PHARMAC, P707
[4]  
Feeny D., 1996, QUALITY LIFE PHARMAC, P239
[5]   SELF-MANAGEMENT, AUTONOMY, AND QUALITY-OF-LIFE IN ASTHMA [J].
GIBSON, PG ;
TALBOT, PI ;
TONEGUZZI, RC .
CHEST, 1995, 107 (04) :1003-1008
[6]   THE IMPACT OF SOCIOECONOMIC-STATUS ON THE INTENSITY OF AMBULATORY TREATMENT AND HEALTH OUTCOMES AFTER HOSPITAL DISCHARGE FOR ADULTS WITH ASTHMA [J].
HAAS, JS ;
CLEARY, PD ;
GUADAGNOLI, E ;
FANTA, C ;
EPSTEIN, AM .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1994, 9 (03) :121-126
[7]  
HINDIALEXANDER MC, 1992, J ASTHMA, V24, P259
[8]  
HOPTON JL, 1992, BRIT J GEN PRACT, V42, P236
[9]   A SCALE FOR ASSESSING QUALITY-OF-LIFE IN ADULT ASTHMA SUFFERERS [J].
HYLAND, ME ;
FINNIS, S ;
IRVINE, SH .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1991, 35 (01) :99-110
[10]   Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma - A randomized controlled trial [J].
Israel, E ;
Cohn, J ;
Dube, L ;
Drazen, JM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (12) :931-936